| PERIOD ENDING | 1-Nov-09 | 2-Aug-09 | 3-May-09 | 1-Feb-09 | | Total Revenue | 52,605 | 45,978 | 52,063 | 56,511 | | Cost of Revenue | 39,928 | 36,283 | 40,836 | 55,627 | | | Gross Profit | 12,677 | 9,695 | 11,227 | 884 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,894 | 10,254 | 11,181 | (2,460) | | Non Recurring |
-
| (60) | 673 | 4,782 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,783 | (499) | (627) | (1,438) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (93) | (26) | (3) | (68) | | Earnings Before Interest And Taxes | 1,690 | (525) | (630) | (1,506) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 1,690 | (525) | (630) | (1,506) | | Income Tax Expense | 733 | (62) | (174) | (787) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 957 | (463) | (456) | (719) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 957 | (463) | (456) | (719) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $957 | ($463) | ($456) | ($719) |
|
0.40% Nasdaq 
Income Statement
